Stocks · News reference

Why Is MIRA Pharmaceuticals Stock Gaining Tuesday?

Sep 1, 2026, 5:12 PMVandana Singh

MIRA Pharmaceuticals (NASDAQ: MIRA) stock jumps as MIRA-55 meets key preclinical study milestones for non-opioid inflammatory pain relief.

More stocks news Connected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source: benzinga
Observed: Sep 1, 2026, 5:12 PM
Checked: Sep 1, 2026, 5:12 PM
Cadence: Captured once, then retained as an archive reference
Status: fresh

Keep reading

BenzingaSep 1, 2026, 3:06 PMBenzinga Newsdesk
MIRA Pharmaceuticals shares are trading higher after the company announced results from the completed 7-day dose-range finding toxicology and toxicokinetic studies of MIRA-55 in rats and dogs.
MIRA
BenzingaSep 1, 2026, 12:02 PMBenzinga Newsdesk
MIRA Pharmaceuticals Says 7-Day Dose-Range Finding Toxicology Studies Of MIRA-55 In Rats And Dogs Completed, Supporting Next Phase Of IND-Enabling Program; Targets IND Submission In Q1 2027
MIRA
SEC EDGARSep 1, 2026, 12:00 PMSEC EDGAR
8-K filing — MIRA PHARMACEUTICALS, INC. (MIRA)
Filed: 2026-09-01 AccNo: 0001493152-26-040930 Size: 238 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
MIRA